Sulfaphenazole
Chemical compound
- J01ED08 (WHO) S01AB05 (WHO) QJ01EQ08 (WHO)
- 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
- 526-08-9
N
- 5335
- DB06729
Y
- 5144 Y
- 0J8L4V3F81
- D01954 Y
- ChEMBL1109 Y
- DTXSID2044131
- Interactive image
- O=S(=O)(c1ccc(N)cc1)Nc3ccnn3c2ccccc2
InChI
- InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2Y
- Key:QWCJHSGMANYXCW-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Sulfaphenazole (or sulfafenazol) is a sulfonamide antibacterial.[1]
References
- ^ Browne SG (1961). "Trial of a long-acting sulfonamide sulfaphenazole (Orisul, Ciba), in the treatment of leprosy". International Journal of Leprosy. 29: 502–5. PMID 13873771.
- v
- t
- e
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
| DHFR inhibitor | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sulfonamides (DHPS inhibitor) |
| ||||||||
| Combinations |
| ||||||||
| Other DHPS inhibitors |
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
| 1st generation | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fluoroquinolones |
| ||||||||
| Newer non-fluorinated | |||||||||
| Related (DG) |
inhibitors
| Nitroimidazole derivatives | |
|---|---|
| Nitrofuran derivatives |
| Rifamycins/ RNA polymerase | |
|---|---|
| Lipiarmycins |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
